Stem cell transplant and graft versus host disease: designing and implementing a steroid-induced hyperglycemia tool kit
- 23 October 2025
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (11) , 1-8
Abstract
Purpose Patients receiving glucocorticoids for acute graft versus host disease (GVHD) after allogeneic hematopoietic stem cell transplant (HSCT) are at risk for developing hyperglycemia and subsequent complications. The primary purpose of this project was to reduce time to medical intervention for steroid-induced hyperglycemia through the implementation of a tailored tool kit for HSCT clinicians. Methods An interdisciplinary team conducted a four-phase project: (1) a baseline chart audit and survey of advanced practice providers (APPs), (2) development of a tool kit and educational materials, (3) education of the HSCT team, and (4) post tool kit implementation chart audit and APP surveys. Results Patients at baseline (N = 15) and post tool kit implementation (N = 8) were diagnosed with acute GVHD with ≥ 0.5 mg/kg/day prednisone and subsequent steroid-induced hyperglycemia. The average number of days to medical intervention was 46 at baseline, reduced to 10 days at 3 months and 9 days at 6 months post tool kit implementation. Metrics used to evaluate changes in APP practice noted an increase in hemoglobin A1c and glucose monitoring from baseline to post tool kit implementation. There was no change in APP confidence scores pre and post tool kit (N = 29). Conclusion The tool kit designed in this study is an evidence-based resource created by an interdisciplinary team that led to earlier intervention to improve glycemic control in HSCT patients. Due to the complex nature of HSCT patients, a proactive and stepwise approach to managing hyperglycemia is critical to monitoring patients at risk and initiating treatment early to mitigate symptoms.Keywords
This publication has 14 references indexed in Scilit:
- Novel developments in the prophylaxis and treatment of acute GVHDBlood, 2023
- Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directionsNature Reviews Endocrinology, 2022
- Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityBone Marrow Transplantation, 2021
- Type 2 Diabetes and its Impact on the Immune SystemCurrent Diabetes Reviews, 2020
- Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trialJournal of Diabetes Investigation, 2018
- Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative reviewDiabetes Research and Clinical Practice, 2018
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and TherapyNew England Journal of Medicine, 2017
- Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2017
- How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCTBone Marrow Transplantation, 2016
- Dysglycemia Following Glucocorticoid Therapy for Acute Graft-versus-Host Disease Adversely Affects Transplantation OutcomesTransplantation and Cellular Therapy, 2011